Identification of New Ketamine Metabolites and Their Detailed Distribution in the Mammalian Brain.
JSON
Vallianatou T, de Souza Anselmo C, Tsiara I, Bèchet NB, Lundgaard I, Globisch D
ACS Chem Neurosci 15 (7) 1335-1341 [2024-04-03; online 2024-03-20]
Ketamine is a common anesthetic used in human and veterinary medicine. This drug has recently received increased medical and scientific attention due to its indications for neurological diseases. Despite being applied for decades, ketamine's entire metabolism and pharmacological profile have not been elucidated yet. Therefore, insights into the metabolism and brain distribution are important toward identification of neurological effects. Herein, we have investigated ketamine and its metabolites in the pig brain, cerebrospinal fluid, and plasma using mass spectrometric and metabolomics analysis. We discovered previously unknown metabolites and validated their chemical structures. Our comprehensive analysis of the brain distribution of ketamine and 30 metabolites describes significant regional differences detected mainly for phase II metabolites. Elevated levels of these metabolites were identified in brain regions linked to clearance through the cerebrospinal fluid. This study provides the foundation for multidisciplinary studies of ketamine metabolism and the elucidation of neurological effects by ketamine.
PubMed 38506562
DOI 10.1021/acschemneuro.4c00051
Crossref 10.1021/acschemneuro.4c00051